Vertex Innovation Awards
The Vertex Innovation Awards fund innovative and collaborative clinical research projects aimed at improving care and outcomes for people with cystic fibrosis.
Funder: Vertex Pharmaceuticals
Due Dates (Anticipated): June 2026 (Vertex Innovation Awards full application deadline, projected)
Funding Amounts: Up to $750,000 per project; up to four projects funded annually.
Summary: Supports innovative and collaborative clinical research to improve care for people with cystic fibrosis.
Description
The Vertex Innovation Awards (VIA) are annual, highly competitive grants designed to advance innovative and collaborative clinical research in cystic fibrosis (CF). VIA aims to support projects that have the potential to significantly improve the care and outcomes for people living with CF. Each year, up to four projects are selected by an independent committee of external experts, with each awarded up to $750,000 USD. The program encourages applications from across the CF research field, provided the lead investigator demonstrates a clear career commitment to CF.
